UNSPSC 51173229: Galactose/lactose/lactulose

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA202. This VA Drug Class (GA202) classifies this compound as belonging to the group HYPEROSMOTIC LAXATIVES.

UNSPSC 51173229 Galactose/lactose/lactulose is a Commodity code that in recent state and local solicitations covers drug testing services, specimen collection, and laboratory confirmation methodologies rather than pharmaceutical ingredients. Collin County Community Supervision and Corrections Department solicited offender specimen collection and drug testing services under RFP 2026-327, requiring immunoassay screening with LC/MS/MS or GC/MS confirmation, oral fluid and hair testing alternatives, and electronic result reporting. The successful vendor must maintain lab certification from SAMHSA, Texas Department of Public Safety, or the College of American Pathologists. Testing volumes run approximately 25,031 tests annually across five-panel and six-panel screens with ancillary testing. This code appears to reflect a misclassification — the recent opportunity solicited testing and collection services rather than galactose or lactose products, suggesting limited activity aligned with the code's nominal pharmaceutical scope.

Collin County in Texas posted the only recent opportunity under this code. The county sought staffing for two collection sites in Plano and McKinney operating Monday through Friday 8:00 a.m. to 5:00 p.m., plus five Saturdays annually, with an estimated contract value of $600,000 across a two-year term commencing September 1, 2026, renewable for three optional one-year periods. Proposals were due July 23, 2026 at 2:00 p.m. The county reserved the right to award in whole or in part to multiple vendors and evaluated offers on vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), and optional Phase 2 demonstrations and interviews (up to 30 points). Pricing was required on a per-test basis under three service models—screening only, confirmation after screening, and screening with automatic confirmation of positives—with no additional surcharges permitted beyond freight, delivery, insurance, and staffing costs.